Navigation Links
Reportlinker Adds Global Immunochemicals Industry
Date:6/14/2011

- US, Canada, Japan, Europe, China and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 52

Table 9: World 15-Year Perspective for Catalog Antibodies by

Geographic Region - Percentage Breakdown of Annual Revenues

for US, Canada, Japan, Europe, China and Rest of World Markets

for Years 2003, 2010 & 2017 (includes corresponding

Graph/Chart) 53

Table 10: World Recent Past, Current & Future Analysis for

Custom Antibodies by Geographic Region - US, Canada, Japan,

Europe, China and Rest of World Markets Independently Analyzed

with Annual Revenue Figures in US$ Million for Years 2009

through 2017 (includes corresponding Graph/Chart) 54

Table 11: World Historic Review for Custom Antibodies by

Geographic Region - US, Canada, Japan, Europe, China and Rest

of World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 55

Table 12: World 15-Year Perspective for Custom Antibodies by

Geographic Region - Percentage Breakdown of Annual Revenues

for US, Canada, Japan, Europe, China and Rest of World Markets

for Years 2003, 2010 & 2017 (includes corresponding

Graph/Chart) 56

10. THE UNITED STATES 57

Market Analysis 57

Table 13: US Recent Past, Current & Future Analysis for

Immunochemicals by Type - Catalog Antibodies and Custom

Antibodies Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 57

Table 14: US Historic Review for Immunochemicals by Type -

Catalog Antibodies and Custom Antibodies Markets

Independently Analyzed with Annual Revenue Figures in US$

Million
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Reportlinker Adds Industrial Biotechnology China News 1105 - Annual Subscription
2. Reportlinker Adds Future of White Biotechnology in China
3. Reportlinker Adds Whats Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015
4. Reportlinker Adds Orthopedic Biomaterials, The World Market
5. Reportlinker Adds Biochips and Microarrays - Technologies, markets and companies
6. Reportlinker Adds Osteosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Future Directions in Regenerative Medicine
8. Reportlinker Adds Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
9. Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
10. Reportlinker Adds Analytical Tool - Lymphoma
11. Reportlinker Adds Enzymes: Sustainable Alternatives with Remarkable Scope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Japan , April 16, 2015  Center ... University and Takeda Pharmaceutical Company Limited (Takeda) announced ... clinical applications of induced pluripotent stem cells in ... disorders and cancer immunotherapy. The "Takeda-CiRA Joint Program ... expedite multiple research projects for drug discovery and ...
(Date:4/16/2015)... Proove Biosciences , Inc. is pleased to ... for the 2015 BIO International Convention. Hosted by the ... will take place June 15-18 at the Pennsylvania Convention ... contest, industry leaders will be voting for companies they ... community voting period began on April 14, 2015 and ...
(Date:4/16/2015)... 16, 2015 OncoTAb, Inc., ... (UNC Charlotte) spin-out company, announced today the appointment ... M.D., as Chief Operating Officer (COO). Cooper brings ... in developing clinical diagnostic and biotechnology platforms in ... , Cooper’s extensive career transcends the field of ...
(Date:4/16/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... venture with G-treeBNT (ReGenTree LLC) has retained Ora, ... for the orphan disorder, neurotrophic keratopathy (NK), and ... syndrome (DES) in the U.S.  Both trials will ... year.  Each of these eye disorders was being ...
Breaking Biology Technology:CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
... a Tool to Make Soyfoods Even HealthierST. LOUIS, March ... healthcare professionals believe soy to be beneficial to the ... method to make food products such as soyfoods even ... Biotechnology Awareness & Attitude Survey - sponsored by ...
... cell line manufacturing, Selexis is now offering a ... drugs with added characterization servicesGENEVA, March 31 ... and services for the rapid development of high-performance ... offering focusing on the biosimilar market segment. ...
... March 31 Sigma-Aldrich (Nasdaq: ... quality services and oligonucleotides to Gene Oracle, an innovative ... agreement, Sigma-Aldrich will be the exclusive supplier of custom ... engage in co-marketing efforts to promote the GeneIOS system ...
Cached Biology Technology:Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 2Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 3Selexis Launches Biosimilar Cell Line Development Program 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 3
(Date:4/2/2015)... 2, 2015 Fingerprint Cards (FPC) ... FPC1025 from the distributor World Peace Industrial Group (WPI), ... 2015 although the major part of the shipments will ... used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK ...
(Date:4/1/2015)... , April 1, 2015   Medisafe ™, the ... users across iOS and Android ... integrating biofeedback into the platform to allow patients to ... For the first time, patients will be able to ... dose impacts important biometrics, such as glucose levels and ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... study of more than 68,000 infants published in this ... Rotateq demonstrated that it can safely prevent 98 percent ... account for 2 million hospital visits and 500,000 pediatric ... largest pre-licensure vaccine clinical trials ever conducted worldwide, research ...
... against the Epstein-Barr virus, the virus that most often ... sclerosis 15 to 20 years later, according to a ... June 2006 print issue of Archives of Neurology, one ... that external factors may influence the risk for multiple ...
... called statins do not appear to reduce the incidence ... of previous studies in the January 4 issue of ... the risk of developing cancer, the authors provide as ... been studied in numerous large-scale, randomized, active- or placebo-controlled ...
Cached Biology News:New vaccine for condition that kills 500,000 children a year 2New vaccine for condition that kills 500,000 children a year 3Epstein-Barr virus may be associated with multiple sclerosis 2Statins have neutral effect on risk of cancer 2
Mouse Anti-Lamin B...
Hybridization Buffer 3.6 ml...
Chicken polyclonal to Thaumatin 2 ( Abpromise for all tested applications). Antigen: Full length Thaumatin 2...
Proteinase K Buffer 3.9 ml...
Biology Products: